You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 276 No. 23, December 18, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sharpen Available Tools for Tuberculosis Control, but New Tools Needed for Elimination

Bess Miller, MD, MSc; Kenneth G. Castro, MD

JAMA. 1996;276(23):1916-1917.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The article by Brewer et al1 in this issue of THE JOURNAL provides an excellent opportunity to assess our nation's progress toward the elimination of tuberculosis (TB). In 1989, the secretary of the US Department of Health and Human Services approved the Strategic Plan for the Elimination of Tuberculosis in the United States.2 In that plan, the elimination of TB is defined as a reduction in the incidence of TB to 1 case per million population by the year 2010. An expert advisory committee deemed TB elimination feasible on the basis of 3 factors: the retreat of TB into geographically and demographically definable foci; the existence of biotechnology to generate improved tools for TB diagnosis, treatment, and prevention; and the availability of computer, telecommunications, and other technologies to enhance the rapid transfer of new technology.

See also p 1898.

Between 1985 and 1992, coincident with the development and . . . [Full Text PDF of this Article]


Author Affiliations

From the Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Ga.


Footnotes

Reprints: Kenneth G. Castro, MD, Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd (E-10), Atlanta, GA 30333 (e-mail: kgc1@cpstb1.em.cdc.gov).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.